US · Healthcare

MYND Lifesciencs Inc (MYNDF)

Biotechnology

MYND Lifesciencs Inc (MYNDF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MYNDF

P/E ratio

18.00

MYND Lifesciencs Inc (MYNDF) — FAQ

What is MYNDF's P/E ratio?

The price-to-earnings (P/E) ratio for MYND Lifesciencs Inc (MYNDF) is 18.00 (data as of 2026-03-24).

Does MYND Lifesciencs Inc pay a dividend?

Dividend yield is not available in the current snapshot for MYND Lifesciencs Inc (MYNDF). Check the MyAverix Finance app for the latest dividend data.

What sector is MYND Lifesciencs Inc in?

MYND Lifesciencs Inc (MYNDF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MYNDF listed on?

MYNDF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)